SCEMBLIX cpr pellic 100 mg 120 pce

7680684410055 CH-68441 L01EA06 07.16.

Active substances:

SCEMBLIX cpr pellic 100 mg 120 pce
SCEMBLIX cpr pellic 100 mg 120 pce
SCEMBLIX cpr pellic 100 mg 120 pce
1 / 3
google

Details

Product number
6844103
CPT
-
Packaging group
120
Unit
Tablette(n)
Composition
asciminibum 100 mg ut asciminibi hydrochloridum 108.1 mg, lactosum monohydricum 215.55 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), E 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, E 172 (rubrum), E 172 (nigrum), xanthani gummi, pro compresso obducto corresp. natrium max. 2.33 mg.

Articles (1)

Scemblix 100 mg, Filmtabletten
Filmtabletten
120
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
24/03/2026
Professional SmPC
Français
24/03/2026
Professional SmPC
Italien
24/03/2026
Patient information leaflet
Allemand
20/01/2026
Patient information leaflet
Français
20/01/2026
Patient information leaflet
Italien
20/01/2026

Detailed composition

Substance Quantity Type Category
asciminibum
100.0 MG Substance Wirkstoff (Principe actif)
asciminibi hydrochloridum
108.1 MG Substance WIZUS
lactosum monohydricum
215.55 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
hydroxypropylcellulosum substitutum humile
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
E 171
- Substance FNIDK
magnesii stearas
- Substance HNIDK
talcum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
lecithinum
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (nigrum)
- Substance FTODK
xanthani gummi
- Substance HNIDK
natrium
- Substance HBESI

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
68441
Drug name
Scemblix, Filmtabletten
Galenic form
FILM
ATC Code
L01EA06
Authorization status
Z
Dispensation category
A
First authorization
09/06/2022
Authorization expiration date
08/06/2027
IT number
07.16.
Domain
Human medicine
Field of application
Behandlung von erwachsenen Patienten mit Philadelphia-Chromosom-positiver chronisch-myeloischer Leukämie (Ph+ CML) in der chronischen Phase (CP)

Packaging details

Description (FR)
SCEMBLIX cpr pellic 100 mg 120 pce
Description (DE)
SCEMBLIX Filmtabl 100 mg 120 Stk
Market launch
15/09/2025
Narcotic (BTM)
No

Other packaging sizes

SCEMBLIX cpr pell 20 mg 60 pce
60 TABL
View
SCEMBLIX cpr pell 40 mg 60 pce
60 TABL
View
Buy us a coffee Explore the data